Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin’s Lymphoma

The aim of the study was to assess the predictive value of interim FDG-PET/CT (iPET) in patients with Hodgkin’s lymphoma (HL) treated with Adriamycin, bleomycin, vinblastine and dacarbazine (ABVD) chemotherapy. A total of 245 consecutive patients with de novo HL between 12/2013 and 12/2017 were eval...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Ibraheem, Akram, Anwer, Farah, Juweid, Malik E., Shagera, Qaid Ahmed, Khalaf, Aysar N., Obeidat, Shahed, Mansour, Areen, Ma’koseh, Mohammad, Halahleh, Khalid, Jaradat, Imad, Almasri, Nidal, Mansour, Asem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587214/
https://www.ncbi.nlm.nih.gov/pubmed/36271128
http://dx.doi.org/10.1038/s41598-022-22032-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587214/
https://www.ncbi.nlm.nih.gov/pubmed/36271128
http://dx.doi.org/10.1038/s41598-022-22032-3

Ejemplares similares